Evidence map›Paper›PMID 39680182›Full record

ArticleJournal of neurology2024

Cuneus atrophy and Parkinsonian phenoconversion in cognitively unimpaired patients with isolated REM sleep behavior disorder.

Andreas Myhre Baun, Alex Iranzo, Miriam Højholt Terkelsen, Morten Gersel Stokholm, Kristian Stær, Mónica Serradell, Marit Otto, Kristina Bacher Svendsen, Alicia Garrido, Dolores Vilas and 8 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Differential Progression of Neuroinflammation in Patients with Isolated Rapid-Eye-Movement Sleep Behavior Disorder.Movement disorders : official journal of the Movement Disorder Society · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Andreas Myhre BaunDepartment of Nuclear Medicine & PET Centre, J220, Aarhus University Hospital, Palle Juul-Jensens Boulevard 165, Aarhus, Denmark. andreasbaun@clin.au.dk.ORCID http://orcid.org/0009-0007-8099-1367
Alex IranzoNeurology Service, Department of Neurology, Hospital Clínic de Barcelona, 08036, Barcelona, Spain. airanzo@clinic.cat.
Miriam Højholt TerkelsenDepartment of Nuclear Medicine & PET Centre, J220, Aarhus University Hospital, Palle Juul-Jensens Boulevard 165, Aarhus, Denmark.
Morten Gersel StokholmDepartment of Nuclear Medicine & PET Centre, J220, Aarhus University Hospital, Palle Juul-Jensens Boulevard 165, Aarhus, Denmark.
Kristian StærDepartment of Nuclear Medicine & PET Centre, J220, Aarhus University Hospital, Palle Juul-Jensens Boulevard 165, Aarhus, Denmark.
Mónica SerradellNeurology Service, Department of Neurology, Hospital Clínic de Barcelona, 08036, Barcelona, Spain.
Marit OttoDepartment of Clinical Neurophysiology, Aarhus University Hospital, Aarhus, Denmark.
Kristina Bacher SvendsenDepartment of Neurology, Aarhus University Hospital, Aarhus, Denmark.
Alicia GarridoCentro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), Hospital Clínic, IDIBAPS, Universitat de Barcelona, Catalonia, Spain.
Dolores VilasCentro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), Hospital Clínic, IDIBAPS, Universitat de Barcelona, Catalonia, Spain.
Joan SantamariaNeurology Service, Department of Neurology, Hospital Clínic de Barcelona, 08036, Barcelona, Spain.
Arne MøllerDepartment of Clinical Medicine, Center of Functionally Integrative Neuroscience, Aarhus University, Aarhus, Denmark.
Carles GaigNeurology Service, Department of Neurology, Hospital Clínic de Barcelona, 08036, Barcelona, Spain.
David J BrooksDepartment of Nuclear Medicine & PET Centre, J220, Aarhus University Hospital, Palle Juul-Jensens Boulevard 165, Aarhus, Denmark.
Per BorghammerDepartment of Nuclear Medicine & PET Centre, J220, Aarhus University Hospital, Palle Juul-Jensens Boulevard 165, Aarhus, Denmark.
Eduardo TolosaCentro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), Hospital Clínic, IDIBAPS, Universitat de Barcelona, Catalonia, Spain.
Simon Fristed EskildsenDepartment of Clinical Medicine, Center of Functionally Integrative Neuroscience, Aarhus University, Aarhus, Denmark.
Nicola PaveseDepartment of Nuclear Medicine & PET Centre, J220, Aarhus University Hospital, Palle Juul-Jensens Boulevard 165, Aarhus, Denmark.

Funding

Danmarks Frie Forskningsfond 4004-00480BDanmarks Frie Forskningsfond 8020-00260BInstituto de Salud Carlos III CB06/05/0018Parkinsonforeningen R4-A104-B60Sundhedsvidenskabelige Fakultet, Aarhus Universitet Bursary
6 · The paper itself

Abstract

Isolated rapid-eye-movement sleep behavior disorder (iRBD) is a strong predictor of Parkinson's disease and Dementia with Lewy bodies. Previous studies indicate that cortical atrophy in iRBD patients may be linked to cognitive impairment, but the pattern of atrophy is inconsistently reported. This study aimed to elucidate cortical atrophy patterns in a cognitively unimpaired iRBD cohort, focusing on regions associated with cognitive functions, particularly the cuneus/precuneus, and evaluated the predictive value for future phenoconversion. We conducted voxel-based morphometry and region of interest (ROI) analysis of structural MRI scans of 36 healthy controls and 19 iRBD patients, nine of whom also received a 3-year follow-up MRI scan. The iRBD patients were followed clinically for 8 years, and time-to-event analyses, using Cox regression, were performed based on baseline ROI volumes. The iRBD patients had lower gray-matter volume in the cuneus/precuneus region as well as in subcortical structures (caudate nuclei and putamen) compared to controls. Eight iRBD patients developed either Parkinson's disease (N = 4) or Dementia with Lewy bodies (N = 4) during the follow-up period. Time-to-event analyses showed that lower right cuneus volume was associated with a higher risk of phenoconversion to alpha-synuclein-linked Parkinsonism in the iRBD patients (Hazard ratio = 13.0, CI: 1.53-110), and correlated with shorter time to conversion. In addition, lower volumes of the bilateral precuneus trended to indicate a higher risk of phenoconversion. These findings suggest a potential predictive value of cuneus and precuneus volumes in identifying iRBD patients at risk of disease progression, even before the onset of cognitive impairment.

Indexed as

AtrophyMagnetic Resonance ImagingParkinson DiseaseREM Sleep Behavior DisorderAgedCognitive DysfunctionDisease ProgressionFemaleFollow-Up StudiesHumansLewy Body DiseaseMaleMiddle AgedBrain atrophyDementiaLewy bodiesParkinson’s diseaseREM sleep behavior disorderVoxel based morphometry

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.